Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of mild to moderate Crohn's disease~* 8 to 18 years old, inclusive~Exclusion Criteria:~* Children less than 8 years or greater than 18 years at the time of study screening~* Patients with a documented history of hypercalcemia, renal insufficiency, or nephrolithiasis~* Patients taking cholestyramine~* Patients who have a GI tract in discontinuity (ostomy)~* Patients who have serum 25-OH vitamin D levels of \>50 ng/mL at the time of study screening

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Children with Crohn's disease less than 35 kg (Type: ACTIVE_COMPARATOR): These are children ages 8 to 18 years inclusive, with mild to moderately active Crohn's disease.
- Children with Crohn's disease 35 kg or greater (Type: ACTIVE_COMPARATOR): These are children ages 8 to 18 years inclusive, with mild to moderately active Crohn's disease.

Based on this trial design, predict the completion outcome and termination type (if applicable).